Romatolojik Hastalıkların ve Mean Platelet Volume DüzeylerininPulmoner Emboli ile İlişkisi

Amaç: Pulmoner emboli (PE), dünyanın her yerinde önemli sağlık problemi olarak gösterilmek-tedir. PE nedeni olan birçok predispoze durum bilinmektedir. PE için kazanılmış ve genetik risk faktörleri mevcuttur ancak hastaların %30’unda neden saptanamamaktadır. Son yıllarda yapılan araştırmalarda yeni risk faktörleri araştırılmaktadır. Bu çalışmada, PE ile Mean Platelet Volume (MPV) değeri ve romatolojik hastalıklar (RH) arasındaki ilişki araştırılmıştır. Yöntem: Çalışmada hastane veri tabanında yer alan kayıtlar kullanılmıştır. Ocak 2008 ve Temmuz 2012 tarihleri arasında PE tanısı almış hastalar retrospektif olarak saptanarak 64 hasta çalışmaya dahil edilmiştir. PE tanısı almış hastalar arasında RH tanısı almış olanlar ve hastaların MPV değerleri ortalamaları belirlenmiştir. Olgu grubuyla aynı zaman aralığında başvuran hastalardan PE ve RH olmayan 64 kişi seçilerek kontrol gurubu oluşturulmuştur. Bulgular: Yapılan analizler sonucunda olgu ve kontrol grupları arasında anlamlı fark olmadığı tespit edilmiştir.Sonuç: Konuya ilişkin planlanacak yeni araştırmalara ihtiyaç olduğu değerlendirilmiştir.

Relation Between Rheumatological Diseases and MPV Levels with Pulmonary Embolism

Objective: Pulmonary Embolism (PE) is shown as an important health problem all over theworld. Many predisposed conditions are known, which are the cause of PE. There are an acquired and genetic risk factors for PE, but in 30% of patients the cause cannot be determined. Thereare so many and genetic risk factors for PE. However, in %30 of patients the cause aren’t determined. New risk factors are being investigated in recent years. In this study, the relationshipbetween PE and the value of mid platelet volume (MPV) and rheumatological diseases (RH) wasstudied. Method: The records in the hospital database were used in the study. Patients diagnosed withPE between January 2008 and July 2012 were determined retrospectively and 64 patients wereincluded in the study. Among patients diagnosed with PE, those diagnosed with RH and average MPV values of patients were determined. A control group was formed by selecting 64patients who were not diagnosed with PE and RH from the patients who applied at the sametime interval with the case group.Among the patients with PE and who are diagnosed with theRD and whose values of MPV were determined. PE patiends and Rheumatologic patients whoare diagnosed with PE and whose values of MPV were compared. Results: As a result of the analyzes, it was determined that there was no significant differencebetween the case and control groups. Conclusion: As a result, it is evaluated that there is a need for new research to be planned onthe subject.

PDF

___

1. Creager MA, Joshua A Beckman JA, Loscalzo J. Vascular medicine: a companion to Braunwald’s heart disease. El- sevier. Philadelphia PA. 2019.
2. Arseven O, Sevinç C, Alataş F, Ekim N, Erkan L, Fındık S, Karabay Ö, Metintaş M, Müsellim B, Oğuzülgen İK, Okumuş NG. Türk Toraks Derneği Pulmoner Tromboem- bolizm Tanı ve Tedavi uzlaşı Raporu cep Kitabı. Aves Ya- yıncılık. Istanbul. 2015.
3. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: is there a practical index of trombosit activity? Clin Appl Thromb. 2003;9(3):177-90. https://doi.org/10.1177/107602960300900301
4. Chu S, Becker R, Berger P, Bhatt D, et al. Mean trombo- sit volume as a predictor of cardiovascular risk: a syste- matic review and metaanalysis. J Thromb Haemost. 2010;8(1):148-56. https://doi.org/10.1111/j.1538-7836.2009.03584.x
5. Colkesen Y, Acil T, Abayli B, Yigit F, Katircibasi T, Kocum T, Demircan S, Sezgin A, Ozin B, Muderrisoglu H. Mean platelet volume is elevated during paroxysmal atrial fib- rillation: a marker of increased platelet activation?. Blood Coagulation & Fibrinolysis. 2008;19(5):411-4. https://doi.org/10.1097/MBC.0b013e3283049697
6. Gonzalez RA, Pla JJ, Tirado CF, Marmol CL, Castillo PO, Ruzafa AL. The Increased Risk of Thromboembolic Events in Patients with Rheumatoid Arthritis. The Journal of Rhe- umatology. 2020;47(1):160-160. https://doi.org/10.3899/jrheum.190899
7. Korniluk A, Koper-Lenkiewicz OM, Kaminska J, Kemona H, Dymicka-Piekarska V. Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions. Mediators of inf- lammation 2019. https://doi.org/10.1155/2019/9213074
8. Varol E et al. Platelet indices in patients with acute pul- monary embolism. Scandinavian Journal of Clinical and Laboratory Investigation. 2011;71(2):163-7. https://doi.org/10.3109/00365513.2010.547596
9. Memiş M, Çelik GK, Şener A, Kavaklı HŞ, İçme F, Karaka- yalı O, Yıldırım H. Pulmoner tromboemboli hastalarında ortalama trombosit hacmindeki değişiklikler. Cukurova Medical Journal. 2016;41(3):498-503. https://doi.org/10.17826/cukmedj.237502
10. Günay E, Ulaşlı SS, Kacar E, Halici B, Unlu E, Tünay K, Özkeçeci G, Köken T, Unlu M. Can platelet indices predict obstruction level of pulmonary vascular bed in patients with acute pulmonary embolism? The Clinical Respiratory Journal. 2014;8(1):33-40. https://doi.org/10.1111/crj.12031
11. Kaymaz D, Ergün P, Candemır I. Romatoid Artrit ve Pul- moner Emboli Birlikteliği: Üç Olgu Sunumu. Respiratory Case Reports. 2016;5(1):53-6. https://doi.org/10.5505/respircase.2016.77150
12. Başol N, Karaman S, Kaya İ, Hasgül B. Romatoid Art- rit Zemininde Gelişen Bir Pulmoner Emboli Olgusu. 2015;7(3):218-23.
13. Kalaycı B, Korkmaz A, Kalaycı S, Duman İ. Romatoid Art- riti Olan Hastada Masif Pulmoner Tromboemboli ve Başa- rılı Trombolitik Tedavisi. 2017;24(1):24-6.
14. Chung WS, Peng CL, Lin CL, Chang YJ, Chen YF, Chiang JY, Fung-Chang S, Kao, CH.. Rheumatoid arthritis incre- ases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Annals of the Rheumatic Diseases. 2014;73(10):1774-80. https://doi.org/10.1136/annrheumdis-2013-203380
15. Lee JJ, Pope JE. A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases. Arthritis Research & Therapy. 2014;16(5):435. https://doi.org/10.1186/s13075-014-0435-y
16. Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Aviña-Zubieta JA, Zhang Y. The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population- based outpatient cohort study. Annals of the rheumatic diseases. 2013;72(7):1182-7. https://doi.org/10.1136/annrheumdis-2012-201669
17. Cozby P, Bates S. Methods in Behavioral Research. New York: McGraw-Hill. 2012.
18. Grjibovski AM, Ivanov SV. Cohort studies in health scien- ces. Science & Healthcare. 2015;3:5-16.
19. Açıkel C. Meta-analiz ve Kanıta Dayalı Tıp’taki Yeri. Klinik Psikofarmakoloji Bulteni. 2009;19(2):164-72.